Pesticide exposure and risk of aggressive prostate cancer among private pesticide applicators.


Journal

Environmental health : a global access science source
ISSN: 1476-069X
Titre abrégé: Environ Health
Pays: England
ID NLM: 101147645

Informations de publication

Date de publication:
05 03 2020
Historique:
received: 13 11 2019
accepted: 20 02 2020
entrez: 7 3 2020
pubmed: 7 3 2020
medline: 21 10 2020
Statut: epublish

Résumé

Prostate cancer (PCa) is one of the most commonly diagnosed cancers among men in developed countries; however, little is known about modifiable risk factors. Some studies have implicated organochlorine and organophosphate insecticides as risk factors (particularly the organodithioate class) and risk of clinically significant PCa subtypes. However, few studies have evaluated other pesticides. We used data from the Agricultural Health Study, a large prospective cohort of pesticide applicators in North Carolina and Iowa, to extend our previous work and evaluate 39 additional pesticides and aggressive PCa. We used Cox proportional hazards models, with age as the time scale, to calculate hazard ratios (HRs) and 95% confidence intervals (CIs) for the association between ever use of individual pesticides and 883 cases of aggressive PCa (distant stage, poorly differentiated grade, Gleason score ≥ 7, or fatal prostate cancer) diagnosed between 1993 and 2015. All models adjusted for birth year, state, family history of PCa, race, and smoking status. We conducted exposure-response analyses for pesticides with reported lifetime years of use. There was an increased aggressive PCa risk among ever users of the organodithioate insecticide dimethoate (n = 54 exposed cases, HR = 1.37, 95% CI = 1.04, 1.80) compared to never users. We observed an inverse association between aggressive PCa and the herbicide triclopyr (n = 35 exposed cases, HR = 0.68, 95% CI = 0.48, 0.95), with the strongest inverse association for those reporting durations of use above the median (≥ 4 years; n = 13 exposed cases, HR=0.44, 95% CI=0.26, 0.77). Few additional pesticides were associated with prostate cancer risk after evaluation of extended data from this large cohort of private pesticide applicators.

Sections du résumé

BACKGROUND
Prostate cancer (PCa) is one of the most commonly diagnosed cancers among men in developed countries; however, little is known about modifiable risk factors. Some studies have implicated organochlorine and organophosphate insecticides as risk factors (particularly the organodithioate class) and risk of clinically significant PCa subtypes. However, few studies have evaluated other pesticides. We used data from the Agricultural Health Study, a large prospective cohort of pesticide applicators in North Carolina and Iowa, to extend our previous work and evaluate 39 additional pesticides and aggressive PCa.
METHODS
We used Cox proportional hazards models, with age as the time scale, to calculate hazard ratios (HRs) and 95% confidence intervals (CIs) for the association between ever use of individual pesticides and 883 cases of aggressive PCa (distant stage, poorly differentiated grade, Gleason score ≥ 7, or fatal prostate cancer) diagnosed between 1993 and 2015. All models adjusted for birth year, state, family history of PCa, race, and smoking status. We conducted exposure-response analyses for pesticides with reported lifetime years of use.
RESULTS
There was an increased aggressive PCa risk among ever users of the organodithioate insecticide dimethoate (n = 54 exposed cases, HR = 1.37, 95% CI = 1.04, 1.80) compared to never users. We observed an inverse association between aggressive PCa and the herbicide triclopyr (n = 35 exposed cases, HR = 0.68, 95% CI = 0.48, 0.95), with the strongest inverse association for those reporting durations of use above the median (≥ 4 years; n = 13 exposed cases, HR=0.44, 95% CI=0.26, 0.77).
CONCLUSION
Few additional pesticides were associated with prostate cancer risk after evaluation of extended data from this large cohort of private pesticide applicators.

Identifiants

pubmed: 32138787
doi: 10.1186/s12940-020-00583-0
pii: 10.1186/s12940-020-00583-0
pmc: PMC7059337
doi:

Substances chimiques

Pesticides 0

Types de publication

Journal Article Research Support, N.I.H., Intramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

30

Subventions

Organisme : Intramural NIH HHS
ID : Z01 CP010119
Pays : United States
Organisme : Intramural NIH HHS
ID : Z01 ES049030
Pays : United States

Références

Environ Health Perspect. 2015 Apr;123(4):317-23
pubmed: 25493337
Nutr Cancer. 2007;58(1):28-34
pubmed: 17571964
Cancer Causes Control. 2019 Apr;30(4):311-322
pubmed: 30805813
Am J Ind Med. 1993 May;23(5):729-42
pubmed: 8506851
J Natl Cancer Inst. 1994 Nov 16;86(22):1718-9
pubmed: 7966401
Int J Cancer. 2015 Nov 1;137(9):2124-32
pubmed: 25904191
Environ Res. 1984 Aug;34(2):193-211
pubmed: 6378617
Reprod Toxicol. 2008 Feb;25(2):184-91
pubmed: 18249523
Scand J Work Environ Health. 1992 Aug;18(4):209-15
pubmed: 1411362
Scand J Work Environ Health. 2016 Mar;42(2):144-52
pubmed: 26932763
Int J Cancer. 2015 Dec 15;137(12):2795-802
pubmed: 25557753
J Androl. 2005 May-Jun;26(3):422-8
pubmed: 15867011
Hum Toxicol. 1989 Nov;8(6):431-7
pubmed: 2591984
Toxicology. 2017 Aug 15;389:13-20
pubmed: 28705778
Cancer Epidemiol Biomarkers Prev. 2009 Feb;18(2):570-4
pubmed: 19155436
Sci Total Environ. 2012 May 1;424:351-5
pubmed: 22425279
PLoS One. 2013 Apr 04;8(4):e58195
pubmed: 23593118
Occup Environ Med. 2007 Mar;64(3):155-60
pubmed: 16912087
Epidemiology. 2006 Jan;17(1):61-8
pubmed: 16357596
Int Arch Occup Environ Health. 2004 Nov;77(8):559-70
pubmed: 15688248
Occup Environ Med. 2011 Jul;68(7):537-41
pubmed: 21257983
J Urol. 2002 Dec;168(6):2431-3
pubmed: 12441933
Epidemiology. 2002 Jan;13(1):94-9
pubmed: 11805592
Chemosphere. 2010 Sep;81(4):464-8
pubmed: 20817259
J Clin Oncol. 2010 Jul 20;28(21):3457-62
pubmed: 20566993
Am J Epidemiol. 2013 Jan 1;177(1):59-74
pubmed: 23171882
Mcgill J Med. 2009 Jan;12(1):70-7
pubmed: 19753293
J Expo Anal Environ Epidemiol. 2002 Sep;12(5):313-8
pubmed: 12198579
Nat Genet. 2018 Jul;50(7):928-936
pubmed: 29892016
Prostate. 2008 May 1;68(6):610-9
pubmed: 18196550
Prostate. 2011 Feb 1;71(2):168-83
pubmed: 20799287
Environ Health Perspect. 2015 Sep;123(9):867-72
pubmed: 25734605
J Occup Environ Med. 2013 Oct;55(10):1171-8
pubmed: 24064777
PLoS One. 2012;7(10):e47730
pubmed: 23118893
Environ Health Perspect. 1996 Apr;104(4):362-9
pubmed: 8732939

Auteurs

Larissa A Pardo (LA)

Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, 9609 Medical Center Drive, Rockville, MD, 20850, USA.

Laura E Beane Freeman (LE)

Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, 9609 Medical Center Drive, Rockville, MD, 20850, USA.

Catherine C Lerro (CC)

Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, 9609 Medical Center Drive, Rockville, MD, 20850, USA.

Gabriella Andreotti (G)

Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, 9609 Medical Center Drive, Rockville, MD, 20850, USA.

Jonathan N Hofmann (JN)

Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, 9609 Medical Center Drive, Rockville, MD, 20850, USA.

Christine G Parks (CG)

National Institute of Environmental Health Sciences, 111 T.W. Alexander Drive, Research Triangle Park, NC, 27709, USA.

Dale P Sandler (DP)

National Institute of Environmental Health Sciences, 111 T.W. Alexander Drive, Research Triangle Park, NC, 27709, USA.

Jay H Lubin (JH)

Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, 9609 Medical Center Drive, Rockville, MD, 20850, USA.

Aaron Blair (A)

Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, 9609 Medical Center Drive, Rockville, MD, 20850, USA.

Stella Koutros (S)

Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, 9609 Medical Center Drive, Rockville, MD, 20850, USA. koutross@mail.nih.gov.
Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, 9609 Medical Center Dr., Room #6E616, MSC 9771, Bethesda, MD, 20892, USA. koutross@mail.nih.gov.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH